Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study
ObjectiveCurrent guidelines recommend the gastric cancer risk score scale (GCRSS) for screening in gastric cancer (GC) high-risk populations in China. This study aimed to estimate the clinical benefits, harms, cost, and cost-effectiveness of the GCRSS screening strategy from a Chinese healthcare sys...
Main Authors: | Shuxia Qin, Xuehong Wang, Sini Li, Chongqing Tan, Xiaohui Zeng, Meiyu Wu, Ye Peng, Liting Wang, Xiaomin Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.955120/full |
Similar Items
-
Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis
by: Jichun Yang, et al.
Published: (2023-09-01) -
Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study
by: Yin Liu, et al.
Published: (2024-02-01) -
Development of a Low-Cost Gastroscope Prototype (GP) for Potential Cost-Effective Gastric Cancer Screening in Prevalent Regions
by: James Xu, et al.
Published: (2023-03-01) -
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
by: Dominik Menges, et al.
Published: (2023-05-01) -
Assessment of Endoscopic Gastric Atrophy according to the Kimura-Takemoto Classification and Its Potential Application in Daily Practice
by: Duc Trong Quach, et al.
Published: (2019-07-01)